These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39201075)

  • 1. Eosinophilic Bronchiectasis: Prevalence, Severity, and Associated Features-A Cohort Study.
    Campisi R; Nolasco S; Mancuso M; Spinella M; Vignera F; Crimi N; Vancheri C; Crimi C
    J Clin Med; 2024 Aug; 13(16):. PubMed ID: 39201075
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous evaluation of the fractional exhaled nitric oxide and blood eosinophil count of T2-high endotype in patients with non-cystic fibrosis bronchiectasis.
    Chen F; Zeng Z; Huang X; Liu Y
    Chron Respir Dis; 2023; 20():14799731231210559. PubMed ID: 37889184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 Biomarkers and Their Clinical Implications in Bronchiectasis: A Prospective Cohort Study.
    Chen YF; Hou HH; Chien N; Lu KZ; Chen YY; Hung ZC; Chien JY; Wang HC; Yu CJ
    Lung; 2024 Oct; 202(5):695-709. PubMed ID: 38884647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Eosinophil Counts in Acute Exacerbations of Bronchiectasis: Unveiling a Distinct Clinical Phenotype.
    Chen W; Ran S; Li C; Li Z; Wei N; Li J; Li N
    Lung; 2024 Feb; 202(1):53-61. PubMed ID: 38228883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Bronchiectasis Severity Index and FACED score for assessment of the severity of bronchiectasis.
    Costa JC; Machado JN; Ferreira C; Gama J; Rodrigues C
    Pulmonology; 2018 Jan; ():. PubMed ID: 29306672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbations and Pseudomonas aeruginosa colonization are associated with altered lung structure and function in primary ciliary dyskinesia.
    Piatti G; De Santi MM; Farolfi A; Zuccotti GV; D'Auria E; Patria MF; Torretta S; Consonni D; Ambrosetti U
    BMC Pediatr; 2020 Apr; 20(1):158. PubMed ID: 32284045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T2-High Endotype and Response to Biological Treatments in Patients with
    Oriano M; Gramegna A; Amati F; D'Adda A; Gaffuri M; Contoli M; Bindo F; Simonetta E; Di Francesco C; Santambrogio M; Sotgiu G; Blasi F; Aliberti S
    Biomedicines; 2021 Jul; 9(7):. PubMed ID: 34356836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The U-Shaped Relationship Between Eosinophil Count and Bronchiectasis Severity: The Effect of Inhaled Corticosteroids.
    Martínez-García MÁ; Méndez R; Olveira C; Girón R; García-Clemente M; Máiz L; Sibila O; Golpe R; Rodríguez-Hermosa JL; Barreiro E; Prados C; Rodríguez-López J; Oscullo G; Labarca G; de la Rosa D
    Chest; 2023 Sep; 164(3):606-613. PubMed ID: 37088355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
    McDowell PJ; Diver S; Yang F; Borg C; Busby J; Brown V; Shrimanker R; Cox C; Brightling CE; Chaudhuri R; Pavord ID; Heaney LG;
    Lancet Respir Med; 2021 Oct; 9(10):1174-1184. PubMed ID: 33971168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Non-Cystic Fibrosis Bronchiectasis Severity: The FACED Score vs the Bronchiectasis Severity Index.
    Minov J; Karadzinska-Bislimovska J; Vasilevska K; Stoleski S; Mijakoski D
    Open Respir Med J; 2015; 9():46-51. PubMed ID: 25893025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic utility of various multidimensional grading scales among Saudi patients with bronchiectasis.
    Al-Harbi A; Al-Ghamdi M; Abdulrahman A; Khan M; Al-Rajhi S; Al-Jahdali H
    Respir Med Res; 2021 Nov; 80():100843. PubMed ID: 34174526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Fibrinogen as a Biomarker for Disease Severity and Exacerbation in Patients with Non-Cystic Fibrosis Bronchiectasis.
    Lee SJ; Jeong JH; Heo M; Ju S; Yoo JW; Jeong YY; Lee JD
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887712
    [No Abstract]   [Full Text] [Related]  

  • 13. Performance of Multidimensional Severity Scoring Systems in Patients with Post-Tuberculosis Bronchiectasis.
    Al-Harbi A; Al-Ghamdi M; Khan M; Al-Rajhi S; Al-Jahdali H
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2157-2165. PubMed ID: 32982208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting mortality in non-cystic fibrosis bronchiectasis patients using distance-saturation product.
    Lin CY; Hsieh MH; Fang YF; Peng CW; Ju JS; Lo YL; Lin SM; Lin HC
    Ann Med; 2021 Dec; 53(1):2034-2040. PubMed ID: 34761709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma.
    Porsbjerg CM; Townend J; Bergeron C; Christoff GC; Katsoulotos GP; Larenas-Linnemann D; Tran TN; Al-Lehebi R; Bosnic-Anticevich SZ; Busby J; Hew M; Kostikas K; Papadopoulos NG; Pfeffer PE; Popov TA; Rhee CK; Sadatsafavi M; Tsai MJ; Ulrik CS; Al-Ahmad M; Altraja A; Beastall A; Bulathsinhala L; Carter V; Cosio BG; Fletton K; Hansen S; Heaney LG; Hubbard RB; Kuna P; Murray RB; Nagano T; Pini L; Cano Rosales DJ; Schleich F; Wechsler ME; Amaral R; Bourdin A; Brusselle GG; Chen W; Chung LP; Denton E; Fonseca JA; Hoyte F; Jackson DJ; Katial R; Kirenga BJ; Koh MS; Ławkiedraj A; Lehtimäki L; Liew MF; Mahboub B; Martin N; Menzies-Gow AN; Pang PH; Papaioannou AI; Patel PH; Perez-De-Llano L; Peters MJ; Ricciardi L; Rodríguez-Cáceres B; Solarte I; Tay TR; Torres-Duque CA; Wang E; Zappa M; Abisheganaden J; Assing KD; Costello RW; Gibson PG; Heffler E; Máspero J; Nicola S; Perng Steve DW; Puggioni F; Salvi S; Sheu CC; Sirena C; Taillé C; Tan TL; Bjermer L; Canonica GW; Iwanaga T; Jiménez-Maldonado L; Taube C; Brussino L; Price DB
    Front Immunol; 2024; 15():1361891. PubMed ID: 38711495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In bronchiectasis, poor physical capacity correlates with poor quality of life.
    Mäntylä J; Mazur W; Törölä T; Bergman P; Kauppi P
    Eur Clin Respir J; 2022; 9(1):2095104. PubMed ID: 35800900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study.
    Crimi C; Campisi R; Nolasco S; Ferri S; Cacopardo G; Impellizzeri P; Pistorio MP; Fagone E; Pelaia C; Heffler E; Crimi N
    J Asthma Allergy; 2021; 14():1441-1452. PubMed ID: 34880630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic performance of the FACED score and bronchiectasis severity index in bronchiectasis: a systematic review and meta-analysis.
    He M; Zhu M; Wang C; Wu Z; Xiong X; Wu H; Cheng D; Ji Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33057706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations.
    Price DB; Bosnic-Anticevich S; Pavord ID; Roche N; Halpin DMG; Bjermer L; Usmani OS; Brusselle G; Ming SWY; Rastogi S
    Clin Transl Allergy; 2019; 9():41. PubMed ID: 31452870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 Low Biomarker Stability and Exacerbations in Severe Uncontrolled Asthma.
    Viinanen A; Aakko J; Lassenius MI; Telg G; Nieminen K; Kaijala S; Lehtimäki L; Kankaanranta H
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.